130 related articles for article (PubMed ID: 36460932)
1. Ruxolitinib enhances cytotoxic and apoptotic effects of temozolomide on glioblastoma cells by regulating WNT signaling pathway-related genes.
Goker Bagca B; Ozates NP; Biray Avci C
Med Oncol; 2022 Dec; 40(1):37. PubMed ID: 36460932
[TBL] [Abstract][Full Text] [Related]
2. Propolis Extract Regulates microRNA Expression in Glioblastoma and Brain Cancer Stem Cells.
C Yilmaz U; Bagca BG; Karaca E; Durmaz A; Durmaz B; Aykut A; Kayalar H; Avci CB; Susluer SY; Pariltay E; Gunduz C; Cogulu O
Anticancer Agents Med Chem; 2022; 22(2):378-389. PubMed ID: 33949939
[TBL] [Abstract][Full Text] [Related]
3. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S
Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849
[TBL] [Abstract][Full Text] [Related]
4. Combination Therapy with Nanomicellar-Curcumin and Temozolomide for In Vitro Therapy of Glioblastoma Multiforme via Wnt Signaling Pathways.
Bagherian A; Mardani R; Roudi B; Taghizadeh M; Banfshe HR; Ghaderi A; Davoodvandi A; Shamollaghamsari S; Hamblin MR; Mirzaei H
J Mol Neurosci; 2020 Oct; 70(10):1471-1483. PubMed ID: 32666415
[TBL] [Abstract][Full Text] [Related]
5. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N
J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502
[TBL] [Abstract][Full Text] [Related]
6. 20(S)-ginsenoside-Rg3 reverses temozolomide resistance and restrains epithelial-mesenchymal transition progression in glioblastoma.
Chen Z; Wei X; Shen L; Zhu H; Zheng X
Cancer Sci; 2019 Jan; 110(1):389-400. PubMed ID: 30431207
[TBL] [Abstract][Full Text] [Related]
7. Microarray expression profiles and bioinformatics analysis of mRNAs, lncRNAs, and circRNAs in the secondary temozolomide-resistant glioblastoma.
Zhao C; Gao Y; Guo R; Li H; Yang B
Invest New Drugs; 2020 Oct; 38(5):1227-1235. PubMed ID: 31823158
[TBL] [Abstract][Full Text] [Related]
8. Sulforaphane enhances temozolomide-induced apoptosis because of down-regulation of miR-21 via Wnt/β-catenin signaling in glioblastoma.
Lan F; Pan Q; Yu H; Yue X
J Neurochem; 2015 Sep; 134(5):811-8. PubMed ID: 25991372
[TBL] [Abstract][Full Text] [Related]
9. Proteins of the Wnt signaling pathway as targets for the regulation of CD133+ cancer stem cells in glioblastoma.
Shevchenko V; Arnotskaya N; Korneyko M; Zaytsev S; Khotimchenko Y; Sharma H; Bryukhovetskiy I
Oncol Rep; 2019 May; 41(5):3080-3088. PubMed ID: 30864699
[TBL] [Abstract][Full Text] [Related]
10. Temozolomide treatment combined with AZD3463 shows synergistic effect in glioblastoma cells.
Goker Bagca B; Ozates NP; Asik A; Caglar HO; Gunduz C; Biray Avci C
Biochem Biophys Res Commun; 2020 Dec; 533(4):1497-1504. PubMed ID: 33109342
[TBL] [Abstract][Full Text] [Related]
11. PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C/EBPβ degradation to facilitate proneural-to-mesenchymal transition.
Gao Z; Xu J; Fan Y; Qi Y; Wang S; Zhao S; Guo X; Xue H; Deng L; Zhao R; Sun C; Zhang P; Li G
J Exp Clin Cancer Res; 2022 Jul; 41(1):223. PubMed ID: 35836243
[TBL] [Abstract][Full Text] [Related]
12. The Dose Dependent Effects of Ruxolitinib on the Invasion and Tumorigenesis in Gliomas Cells via Inhibition of Interferon Gamma-Depended JAK/STAT Signaling Pathway.
Delen E; Doğanlar O
J Korean Neurosurg Soc; 2020 Jul; 63(4):444-454. PubMed ID: 32492985
[TBL] [Abstract][Full Text] [Related]
13. FERMT3 contributes to glioblastoma cell proliferation and chemoresistance to temozolomide through integrin mediated Wnt signaling.
Lu C; Cui C; Liu B; Zou S; Song H; Tian H; Zhao J; Li Y
Neurosci Lett; 2017 Sep; 657():77-83. PubMed ID: 28778805
[TBL] [Abstract][Full Text] [Related]
14. COXIBs and 2,5-dimethylcelecoxib counteract the hyperactivated Wnt/β-catenin pathway and COX-2/PGE2/EP4 signaling in glioblastoma cells.
Majchrzak-Celińska A; Misiorek JO; Kruhlenia N; Przybyl L; Kleszcz R; Rolle K; Krajka-Kuźniak V
BMC Cancer; 2021 May; 21(1):493. PubMed ID: 33941107
[TBL] [Abstract][Full Text] [Related]
15. WNT signaling modulates chemoresistance to temozolomide in p53-mutant glioblastoma multiforme.
Ma Z; Cai S; Xiong Q; Liu W; Xia H; Zhu Z; Huang Z; Yan X; Wang Q
Apoptosis; 2022 Feb; 27(1-2):80-89. PubMed ID: 35037107
[TBL] [Abstract][Full Text] [Related]
16. Temozolomide downregulates P-glycoprotein expression in glioblastoma stem cells by interfering with the Wnt3a/glycogen synthase-3 kinase/β-catenin pathway.
Riganti C; Salaroglio IC; Caldera V; Campia I; Kopecka J; Mellai M; Annovazzi L; Bosia A; Ghigo D; Schiffer D
Neuro Oncol; 2013 Nov; 15(11):1502-17. PubMed ID: 23897632
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the Invasion of Human Glioblastoma U87 Cell Line by Ruxolitinib: A Molecular Player of miR-17 and miR-20a Regulating JAK/STAT Pathway.
Delen E; Doganlar O; Doganlar ZB; Delen O
Turk Neurosurg; 2020; 30(2):182-189. PubMed ID: 31452174
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-128-3p Enhances the Chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT.
Zhao C; Guo R; Guan F; Ma S; Li M; Wu J; Liu X; Li H; Yang B
Sci Rep; 2020 Jun; 10(1):9471. PubMed ID: 32528036
[TBL] [Abstract][Full Text] [Related]
19. Ruxolitinib Regulates the Autophagy Machinery in Multiple Myeloma Cells.
Kusoglu A; Bagca BG; Ay NPO; Saydam G; Avci CB
Anticancer Agents Med Chem; 2020; 20(18):2316-2323. PubMed ID: 32067619
[TBL] [Abstract][Full Text] [Related]
20. Temozolomide induces activation of Wnt/β-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy.
Tomar VS; Patil V; Somasundaram K
Cell Biol Toxicol; 2020 Jun; 36(3):273-278. PubMed ID: 31758290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
